SCHEMBL11997031

SCHEMBL11997031

CCc1cc(Nc2cc(=O)n(CCCCN3CCN(c4c(F)cc5c(=O)c(C(=O)O)cn(C6CC6)c5c4F)CC3OC)c(=O)[nH]2)ccc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6778740 0.92 — —
SCHEMBL4741950 0.92 — —
SCHEMBL11967746 0.92 — —
SCHEMBL11967768 0.92 — —
SCHEMBL6777194 0.91 — —
SCHEMBL4742001 0.89 — —
SCHEMBL6779885 0.89 TDP1 (0.54) —
SCHEMBL11967784 0.88 — —
SCHEMBL11967818 0.87 — —
SCHEMBL4741925 0.87 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401829-B1 NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS MICROBIOTIX INC (US) 2012-08-22 — — EP disclosed
Send feedback